Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
Status:
Completed
Trial end date:
2020-12-24
Target enrollment:
Participant gender:
Summary
The study will assess the efficacy and safety of DFV890 for the treatment of SARS-Cov-2
infected patients with COVID-19 pneumonia and impaired respiratory function.